chr8-121624601-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005328.3(HAS2):​c.627+4113A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 152,088 control chromosomes in the GnomAD database, including 7,746 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 7746 hom., cov: 32)

Consequence

HAS2
NM_005328.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.76

Publications

5 publications found
Variant links:
Genes affected
HAS2 (HGNC:4819): (hyaluronan synthase 2) Hyaluronan or hyaluronic acid (HA) is a high molecular weight unbranched polysaccharide synthesized by a wide variety of organisms from bacteria to mammals, and is a constituent of the extracellular matrix. It consists of alternating glucuronic acid and N-acetylglucosamine residues that are linked by beta-1-3 and beta-1-4 glycosidic bonds. HA is synthesized by membrane-bound synthase at the inner surface of the plasma membrane, and the chains are extruded through pore-like structures into the extracellular space. It serves a variety of functions, including space filling, lubrication of joints, and provision of a matrix through which cells can migrate. HA is actively produced during wound healing and tissue repair to provide a framework for ingrowth of blood vessels and fibroblasts. Changes in the serum concentration of HA are associated with inflammatory and degenerative arthropathies such as rheumatoid arthritis. In addition, the interaction of HA with the leukocyte receptor CD44 is important in tissue-specific homing by leukocytes, and overexpression of HA receptors has been correlated with tumor metastasis. HAS2 is a member of the newly identified vertebrate gene family encoding putative hyaluronan synthases, and its amino acid sequence shows significant homology to glycosaminoglycan synthetase (DG42) from Xenopus laevis, and human and murine hyaluronan synthase 1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.413 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005328.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS2
NM_005328.3
MANE Select
c.627+4113A>C
intron
N/ANP_005319.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HAS2
ENST00000303924.5
TSL:1 MANE Select
c.627+4113A>C
intron
N/AENSP00000306991.4

Frequencies

GnomAD3 genomes
AF:
0.308
AC:
46863
AN:
151970
Hom.:
7721
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.418
Gnomad AMI
AF:
0.314
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.339
Gnomad EAS
AF:
0.119
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.231
Gnomad MID
AF:
0.380
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.313
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.309
AC:
46933
AN:
152088
Hom.:
7746
Cov.:
32
AF XY:
0.303
AC XY:
22530
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.418
AC:
17333
AN:
41474
American (AMR)
AF:
0.269
AC:
4118
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.339
AC:
1178
AN:
3470
East Asian (EAS)
AF:
0.119
AC:
612
AN:
5162
South Asian (SAS)
AF:
0.199
AC:
961
AN:
4822
European-Finnish (FIN)
AF:
0.231
AC:
2448
AN:
10596
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.283
AC:
19216
AN:
67956
Other (OTH)
AF:
0.315
AC:
667
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1617
3234
4850
6467
8084
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
1253
Bravo
AF:
0.320
Asia WGS
AF:
0.200
AC:
693
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.087
DANN
Benign
0.48
PhyloP100
-2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6998348; hg19: chr8-122636841; API